Patent · US Active

Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine

US9145396B2 · kind B2 · utility

10Cited by

18References

3Claims

0Family size

Assignee

Targacept, Inc. · US

Inventors

Srinivasa Rao Akireddy · Winston-Salem, US
Balwinder Singh Bhatti · Winston-Salem, US
Timothy J. Cuthbertson · Winston-Salem, US
Gary Maurice Dull · Lewisville, US
Craig Harrison Miller · Winston-Salem, US
Joseph Pike Mitchener, Jr. · Winston-Salem, US
Julio A. Munoz · Walnut Cove, US
Pieter Albert Otten · King, US

Key dates

Filing date	Nov 7, 2013
Grant date	Sep 29, 2015
Priority date	—
Expiry date	Nov 7, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C59/265
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.